HK Stock Market Move | IVD MEDICAL (01931) rose another 9% during trading, with a cumulative increase of 200% in the past four weeks. Collaborating with Huada for mutual success in establishing the innovative drug RWA exclusive fund.

date
06/08/2025
avatar
GMT Eight
Huajian Medical (01931) rose another 9% during trading hours, with a cumulative increase of over 200% in the past four weeks. As of the time of writing, it was up 7.3% at HKD 6.17 with a trading volume of 23.3243 million HKD.
IVD MEDICAL (01931) rose by 9% during the day, with a cumulative increase of over 200% in the past four weeks. As of the time of drafting, it rose by 7.3% to HK$6.17, with a transaction amount of 23.3243 million Hong Kong dollars. On the news front, on July 30th, IVD MEDICAL announced a strategic cooperation framework agreement with BGI Genomics, jointly establishing the "Huacheck BGI Win-Win Innovative Drug Intellectual Property Tokenization Fund." The fund will invest in IVD MEDICAL's "NewCo+RWA" Web3 exchange ecosystem projects in Hong Kong, China, the United States, and other locations. As a corporate venture capital (CVC) entity initiated by the biotechnology leader BGI Genomics, Huacheck BGI Win-Win has many years of domestic and foreign investment experience and project resources in the fields of Innovative Medical Management and innovative drugs. In the article "The Eve of the Enactment of Stablecoin Regulations, IVD MEDICAL (01931) Receives Three Actual "Trust Tickets"," the company is pointed out to have built a Web3 exchange ecosystem called "IVDNewCo Exchange", directly addressing the pain points in the pharmaceutical industry: it takes 10 years to develop a new drug, with 80% of funds invested in the clinical stage, while ordinary investors are shut out. IVD MEDICAL's solution is to transform high-value medical assets - such as Phase II clinical ADC drugs, gene therapy patents - into divisible digital certificates through RWA technology for trade. Its goal is clear: to become the "Nasdaq+Uniswap" in the medical RWA field, ensuring compliance and achieving decentralized liquidity.